Cargando…

Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease

BACKGROUND AND OBJECTIVES: This study aims to quantify microglial activation in individuals with Alzheimer disease (AD) using the 18-kDa translocator protein (TSPO) PET imaging in the hippocampus and precuneus, the 2 AD-vulnerable regions, and to evaluate the association of baseline neuroinflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qing, Chen, Gengsheng, Schindler, Suzanne E., Christensen, Jon, McKay, Nicole S., Liu, Jingxia, Wang, Sicheng, Sun, Zhexian, Hassenstab, Jason, Su, Yi, Flores, Shaney, Hornbeck, Russ, Cash, Lisa, Cruchaga, Carlos, Fagan, Anne M., Tu, Zhude, Morris, John C., Mintun, Mark A., Wang, Yong, Benzinger, Tammie L.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906187/
https://www.ncbi.nlm.nih.gov/pubmed/35260470
http://dx.doi.org/10.1212/NXI.0000000000001152
_version_ 1784665355593973760
author Wang, Qing
Chen, Gengsheng
Schindler, Suzanne E.
Christensen, Jon
McKay, Nicole S.
Liu, Jingxia
Wang, Sicheng
Sun, Zhexian
Hassenstab, Jason
Su, Yi
Flores, Shaney
Hornbeck, Russ
Cash, Lisa
Cruchaga, Carlos
Fagan, Anne M.
Tu, Zhude
Morris, John C.
Mintun, Mark A.
Wang, Yong
Benzinger, Tammie L.S.
author_facet Wang, Qing
Chen, Gengsheng
Schindler, Suzanne E.
Christensen, Jon
McKay, Nicole S.
Liu, Jingxia
Wang, Sicheng
Sun, Zhexian
Hassenstab, Jason
Su, Yi
Flores, Shaney
Hornbeck, Russ
Cash, Lisa
Cruchaga, Carlos
Fagan, Anne M.
Tu, Zhude
Morris, John C.
Mintun, Mark A.
Wang, Yong
Benzinger, Tammie L.S.
author_sort Wang, Qing
collection PubMed
description BACKGROUND AND OBJECTIVES: This study aims to quantify microglial activation in individuals with Alzheimer disease (AD) using the 18-kDa translocator protein (TSPO) PET imaging in the hippocampus and precuneus, the 2 AD-vulnerable regions, and to evaluate the association of baseline neuroinflammation with amyloidosis, tau, and longitudinal cognitive decline. METHODS: Twenty-four participants from the Knight Alzheimer Disease Research Center (Knight ADRC) were enrolled and classified into stable cognitively normal, progressor, and symptomatic AD groups based on clinical dementia rating (CDR) at 2 or more clinical assessments. The baseline TSPO radiotracer [11C]PK11195 was used to image microglial activation. Baseline CSF concentrations of Aβ42, Aβ42/Aβ40 ratio, tau phosphorylated at position 181 (p-tau181), and total tau (t-tau) were measured. Clinical and cognitive decline were examined with longitudinal CDR and cognitive composite scores (Global and Knight ADRC-Preclinical Alzheimer Cognitive Composite [Knight ADRC-PACC] Score). RESULTS: Participants in the progressor and symptomatic AD groups had significantly elevated [11C]PK11195 standard uptake value ratios (SUVRs) in the hippocampus but not in the precuneus region. In the subcohort with CSF biomarkers (16 of the 24), significant negative correlations between CSF Aβ42 or Aβ42/Aβ40 and [11C]PK11195 SUVR were observed in the hippocampus and precuneus. No correlations were observed between [11C]PK11195 SUVR and CSF p-tau181 or t-tau at baseline in those regions. Higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions predicted longitudinal decline on cognitive tests. DISCUSSION: Microglial activation is increased in individuals with brain amyloidosis and predicts worsening cognition in AD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with AD, higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions was associated with longitudinal decline on cognitive tests.
format Online
Article
Text
id pubmed-8906187
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-89061872022-03-09 Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease Wang, Qing Chen, Gengsheng Schindler, Suzanne E. Christensen, Jon McKay, Nicole S. Liu, Jingxia Wang, Sicheng Sun, Zhexian Hassenstab, Jason Su, Yi Flores, Shaney Hornbeck, Russ Cash, Lisa Cruchaga, Carlos Fagan, Anne M. Tu, Zhude Morris, John C. Mintun, Mark A. Wang, Yong Benzinger, Tammie L.S. Neurol Neuroimmunol Neuroinflamm Article BACKGROUND AND OBJECTIVES: This study aims to quantify microglial activation in individuals with Alzheimer disease (AD) using the 18-kDa translocator protein (TSPO) PET imaging in the hippocampus and precuneus, the 2 AD-vulnerable regions, and to evaluate the association of baseline neuroinflammation with amyloidosis, tau, and longitudinal cognitive decline. METHODS: Twenty-four participants from the Knight Alzheimer Disease Research Center (Knight ADRC) were enrolled and classified into stable cognitively normal, progressor, and symptomatic AD groups based on clinical dementia rating (CDR) at 2 or more clinical assessments. The baseline TSPO radiotracer [11C]PK11195 was used to image microglial activation. Baseline CSF concentrations of Aβ42, Aβ42/Aβ40 ratio, tau phosphorylated at position 181 (p-tau181), and total tau (t-tau) were measured. Clinical and cognitive decline were examined with longitudinal CDR and cognitive composite scores (Global and Knight ADRC-Preclinical Alzheimer Cognitive Composite [Knight ADRC-PACC] Score). RESULTS: Participants in the progressor and symptomatic AD groups had significantly elevated [11C]PK11195 standard uptake value ratios (SUVRs) in the hippocampus but not in the precuneus region. In the subcohort with CSF biomarkers (16 of the 24), significant negative correlations between CSF Aβ42 or Aβ42/Aβ40 and [11C]PK11195 SUVR were observed in the hippocampus and precuneus. No correlations were observed between [11C]PK11195 SUVR and CSF p-tau181 or t-tau at baseline in those regions. Higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions predicted longitudinal decline on cognitive tests. DISCUSSION: Microglial activation is increased in individuals with brain amyloidosis and predicts worsening cognition in AD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with AD, higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions was associated with longitudinal decline on cognitive tests. Lippincott Williams & Wilkins 2022-03-08 /pmc/articles/PMC8906187/ /pubmed/35260470 http://dx.doi.org/10.1212/NXI.0000000000001152 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Wang, Qing
Chen, Gengsheng
Schindler, Suzanne E.
Christensen, Jon
McKay, Nicole S.
Liu, Jingxia
Wang, Sicheng
Sun, Zhexian
Hassenstab, Jason
Su, Yi
Flores, Shaney
Hornbeck, Russ
Cash, Lisa
Cruchaga, Carlos
Fagan, Anne M.
Tu, Zhude
Morris, John C.
Mintun, Mark A.
Wang, Yong
Benzinger, Tammie L.S.
Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
title Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
title_full Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
title_fullStr Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
title_full_unstemmed Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
title_short Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
title_sort baseline microglial activation correlates with brain amyloidosis and longitudinal cognitive decline in alzheimer disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906187/
https://www.ncbi.nlm.nih.gov/pubmed/35260470
http://dx.doi.org/10.1212/NXI.0000000000001152
work_keys_str_mv AT wangqing baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT chengengsheng baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT schindlersuzannee baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT christensenjon baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT mckaynicoles baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT liujingxia baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT wangsicheng baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT sunzhexian baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT hassenstabjason baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT suyi baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT floresshaney baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT hornbeckruss baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT cashlisa baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT cruchagacarlos baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT faganannem baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT tuzhude baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT morrisjohnc baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT mintunmarka baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT wangyong baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease
AT benzingertammiels baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease